A

Autonomix Medical Inc
NASDAQ:AMIX

Watchlist Manager
Autonomix Medical Inc
NASDAQ:AMIX
Watchlist
Price: 0.423 USD -1.17% Market Closed
Market Cap: $2.9m

Net Margin

0%
Current
No historical data
Comparison unavailable

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
0%
=
$0
/
$0

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
0%
=
$0
/
$0

Peer Comparison

Country Company Market Cap Net
Margin
US
Autonomix Medical Inc
NASDAQ:AMIX
2.9m USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.8B USD
Loading...
US
Dexcom Inc
NASDAQ:DXCM
28.6B USD
Loading...
JP
Terumo Corp
TSE:4543
3T JPY
Loading...
US
Insulet Corp
NASDAQ:PODD
18.5B USD
Loading...
US
ABIOMED Inc
LSE:0H7S
17.2B USD
Loading...
US
Zimmer Biomet Holdings Inc
NYSE:ZBH
17B USD
Loading...
US
West Pharmaceutical Services Inc
NYSE:WST
17.1B USD
Loading...
US
Penumbra Inc
NYSE:PEN
14.1B USD
Loading...
NZ
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
22.7B NZD
Loading...
US
Shockwave Medical Inc
F:36M
11.3B EUR
Loading...

Market Distribution

Not Available
No Country distribution data available for this multiple

Autonomix Medical Inc
Glance View

Market Cap
2.9m USD
Industry
N/A

Autonomix Medical Inc is a US-based company operating in industry. The company is headquartered in The Woodlands, Texas and currently employs 3 full-time employees. The company went IPO on 2024-01-29. Autonomix Medical, Inc. is a medical device company, which is focused on advancing technologies to treat diseases involving the peripheral nervous system. Its technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate peripheral neural signals with up to 1,000 times sensitivity. The company is developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. The company is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation, and chronic pain management across a disease spectrum. Its Autonomix catheter is equipped with a microchip that converts analog signals from the body to a digital signal that can be sent directly to a computer screen.

AMIX Intrinsic Value
0.176 USD
Overvaluation 58%
Intrinsic Value
Price
A
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Back to Top